Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification

16 Feb 2018

Abstract excerpt

// Kentaro Inamura 1 1 Division of Pathology, The Cancer Institute; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan Correspondence to: Kentaro Inamura, email: kentaro.inamura@jfcr.or.jp Keywords: genetic alteration; histology; molecular pathological epidemiology; prostate cancer; The Cancer Genome Atlas (TCGA) Received:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29581876
DOI: 10.18632/oncotarget.24515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classificationPMID 29581876Read ↗

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic TargetsSemantic proximity Read ↗

The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancerSemantic proximity Read ↗

The Genetic Complexity of Prostate Cancer.Semantic proximity Read ↗

Human Prostate Cancer Hallmarks MapSemantic proximity Read ↗

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerSemantic proximity Read ↗

Molecular subtyping of prostate cancer.Semantic proximity Read ↗

Clinical variability and molecular heterogeneity in prostate cancerSemantic proximity Read ↗

Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.Semantic proximity Read ↗

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.Semantic proximity Read ↗

Genomic features of liquid biopsies from patients with prostate cancer with and without ductal adenocarcinoma.Semantic proximity Read ↗

Human prostate cancer precursors and pathobiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.